Oxford Biomedica plc
Save
–
Market cap
–
Current P/E
227.27x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product.
Similar securities
Based on sector and market capitalization
Report issue